Trump's recent announcement that he's procured $7 trillion in incoming investments to the U.S. may very well have been an underestimate.

Novartis appoints Karen Hale as chief legal and compliance officer: Basel Tuesday, April 1, 2025, 13:00 Hrs [IST] Novartis announced the appointment of Karen Hale to the expanded ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as part of its $23 billion investment in U.S. operations over the next five years ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

It has been a choppy week for European and global markets as investors have been reacting to the frequent developments in ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to ...

Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...